Home
Directory
Pricing
Resources
WhoIs
Articles
About
Partners
Contact
Search
Directory of Health Related Domain Names for Sale
Home
Directory
Pricing
Resources
WhoIs
Articles
About
Partners
Contact
Home
Tags
CORO
Tag: CORO
COVID-19 Origins Tied to Raccoon Dogs Sold at Wuhan Market
Symptom and Viral RNA Rebound Common After Mild, Moderate COVID-19
Natural Protection Against Reinfection With BA.1 COVID-19 Variant Lower
Pre-Infection Healthy Lifestyle Tied to Lower Risk for Long COVID
Long COVID Explored in University Settings
Post-COVID-19 Conditions Tied to Higher Health Care Utilization
Most Long COVID Resolves Within One Year for Mild Infections
Severity of Acute COVID-19 Tied to Frequency of Long COVID Diagnosis
41.6 Percent of Adults Have Serology Indicative of Past COVID-19 Infection
Temporal Improvement Seen in Standard of Care for Hospitalized COVID-19 Patients
New COVID-19 Variant XBB Gaining Ground Among Americans
Seroprevalence to SARS-CoV-2 Has Increased Over Time
Long COVID Prevalent in U.S. Adults With Prior COVID-19 Infection
Omicron BA.2 Subvariant Less Severe Than Delta, Original Omicron
New Omicron Variants Gaining Foothold in United States
Misrepresentation, Nonadherence to COVID-19 Public Health Measures Common
Plasma Viral Antigen Linked to Baseline Severity of COVID-19
Duration of Infectiousness Examined in COVID-19 Cases
Hospitalization Rates Up During Omicron BA.2 Predominance
Up to 4 Million Americans Out of Work With Long COVID
More Than Half of People Infected With Omicron Variant Were Unaware
First Lady Jill Biden Leaves Isolation After Testing Negative for COVID-19...
Patients Have Higher Health Care Use After COVID-19 Infection
First Lady Jill Biden Has COVID-19
Clinical Guideline Issued for Use of COVID-19 Convalescent Plasma
Biden Tests Negative for COVID-19 Again, Leaves Isolation
Persistence of Somatic Symptoms After COVID-19 Quantified
In COVID ‘Rebound,’ Biden Tests Positive for Second Day in a...
62 Symptoms Linked to SARS-CoV-2 Infection After 12 Weeks
U.S. Extends COVID-19 Public Health Emergency Another Three Months
Spike RBD IgG Antibodies Persist After SARS-CoV-2 Infection
New Omicron Subvariant Spreading in India, United States
One in 13 U.S. Adults Report Long COVID Symptoms
COVID-19 Linked to Increased Risk of Neurological Disorders
Sex Differences Seen in COVID-19 Sequelae, Long COVID
Fauci Tests Positive for COVID-19, Has Mild Symptoms
WHO Experts Open to Notion That China Lab Leak Spurred COVID-19
Two New Omicron Subvariants Gain Ground in the U.S.
Multisystem Abnormalities Persist After COVID-19 Hospitalization
Admission Less Likely for COVID-19 Patients With Omicron Versus Delta
New BA.2 COVID-19 Subvariant Taking Hold in United States
Almost 30 Percent of COVID-19 Patients Develop ‘Long COVID’
New Omicron Subvariant Causing COVID-19 Spike in South Africa
E.U. Says Europe Out of ‘Emergency’ Phase of Pandemic
Natural COVID-19 Immunity Produces Protection Similar to Vaccines
SARS-CoV-2 Seroprevalence Up From Dec. 2021 to Feb. 2022
CDC: Four People Infected With Coronavirus Version Seen in Mink
Cases of Coronavirus Moving From Mink to People Confirmed by CDC
Biden Makes National Push for ‘Long COVID’ Research
Awake Prone Positioning Does Not Improve Outcomes in COVID-19
COVID-19-Associated Hospitalization Rate Up During Omicron
Rise in U.K. COVID-19 Cases Closely Watched by U.S. Health Officials
‘Deltacron’ Variant Rare and Not a Major Concern
New York City Drops Most COVID-19 Restrictions
U.S. Surgeon General Investigates COVID-19 Misinformation
CDC Estimates U.S. COVID-19 Infections Now Close to 140 Million
Boris Johnson Lifts Last COVID-19 Restrictions in England
Prior SARS-CoV-2 Infection Less Protective Against Omicron Variant
Anti-RBD Antibodies Detected Up to 20 Months After COVID-19
CDC Turns to Wastewater Data to Track Spread of COVID-19
SARS-CoV-2 Antibody Tests Should Not Be Used for Diagnosis
‘Stealth’ Version of Omicron Variant No Cause for Alarm, Experts Say
Omicron Linked to Increase in COVID-19 Cases, Lower Disease Severity
Scientists Watch, Worry About New ‘Stealth’ Version of Omicron Variant
Omicron Shows Signs of Ebbing as U.S. Cases Fall, Hospitalizations Level...
AI Model May Predict COVID-19 Outcomes for Critically Ill
COVID-19 Restrictions Eased in England
Too Soon to Tell if Omicron Will End Pandemic: Fauci
U.S. May Soon See Sharp Drop in Omicron Cases, Experts Say
COVID-19 Omicron Wave in South Africa Characterized
CDC Lowers Estimate of Omicron Prevalence in the United States
Omicron Might Help Shield Against Delta, New Research Suggests
Omicron Cases Pass U.S. Peak Seen With Delta
Omicron Now Accounts for 73 Percent of New COVID-19 Cases
Natural Immunity Protects Against SARS-CoV-2 Reinfection
CDC Warns of Coming Omicron Wave
Report Highlights Characteristics of Omicron SARS-CoV-2 Variant in U.S.
For Earlier Variants, Severe COVID-19 Less Likely at Reinfection
Omicron Variant May Overcome Prior COVID-19 Infection
New York Reports Five Omicron Cases, U.S. Total Rises to Nine
Biden to Announce Plan to Battle Omicron, Delta Variants This Winter
Second Omicron Case Reported in Man Who Traveled to NYC Anime...
First U.S. Omicron Case Reported in California
Thanksgiving Weekend Brought New COVID-19 Concerns: the Omicron Variant
Biden Pushes Vaccines, Masks as Best Defense Against Omicron Variant
U.S. COVID-19 Cases, Hospitalizations on the Rise Just Before Thanksgiving
New Review Claims First COVID-19 Patient Was Wuhan Market Vendor
COVID-19 Widespread Among Iowa Deer
‘Delta Plus’ Variant Surfaces in Eight U.S. States
Fully Vaccinated With Breakthrough Infection Can Transmit COVID-19
Health Officials Say U.S. COVID-19 Cases Fell 60 Percent Since September
Severe COVID-19 Outcomes Not Up During Delta Predominance
Delta Variant Subtype on Rise in United Kingdom
Study Confirms Virulence of SARS-CoV-2 Variants of Concern
One-Third Have Symptoms Two Months After SARS-CoV-2
Delta Variant Now Fueling 99 Percent of U.S. COVID-19 Cases
NIH Spending Nearly $470 Million on ‘Long-Haul COVID’ Study
Estimated Population Immunity Against SARS-CoV-2 62.0 Percent
Frequency of Long-Term Symptoms Up With Positive SARS-CoV-2 Test
U.S. COVID-19 Cases Now Top 40 Million
New COVID-19 Cases 300 Percent Higher This Labor Day Weekend Than...
New ‘Mu’ Coronavirus Variant Being Watched Closely: Fauci
Individuals With COVID-19 Most Infectious Around Symptom Onset
Good Recovery at One Year for Most COVID-19 Hospital Survivors
Record High COVID-19 Cases and Deaths Reported in Florida
WHO Team Says Search for Coronavirus Origins at Standstill
Increased Crowding Linked to COVID-19 Incidence in Prisons
Florida Sees Record Number of COVID-19 Cases, Hospitalizations
Despite Reopening, Britain Sees Six Straight Days of Declines in COVID-19...
SARS-CoV-2 Antibodies May Persist Nine Months After Infection
Almost Half of Patients Admitted With COVID-19 Have Complications
New COVID-19 Cases Doubled in U.S. in Past Three Weeks
No Spectators to Be Allowed at Tokyo Olympic Games
COVID-19 Cases Surge in Los Angeles County as Delta Variant Spreads
Delta Variant Now Behind More Than 50 Percent of U.S. COVID-19...
Britain to Fully Reopen Soon, Despite Rising COVID-19 Cases
16.8 Million Undiagnosed COVID-19 Cases in First Six Months in U.S.
Coronavirus Delta Variant Spreading Rapidly in the United States
Obesity Tied to Long-Term COVID-19 Complications
CureVac’s COVID-19 Vaccine Only 47 Percent Effective
U.S. Buys 200 Million Extra Moderna Vaccine Doses, as Possible Booster...
Coronavirus Delta Variant Classified ‘Variant of Concern’ by CDC
New York Lifts Pandemic Restrictions
SARS-CoV-2 Antibodies Identified Before Cases Recognized in U.S.
California Lifts Most COVID-19 Restrictions
Vaccinations More Urgent as Variant That Crippled India Shows Up in...
WHO Says New Coronavirus Variants to Be Named Using Greek Alphabet
Poll Finds Herd Immunity in U.S. Possible by Summer
Review Shows COVID-19 Symptoms Often Linger
U.S. Intelligence Told to ‘Redouble’ Efforts to Determine Source of COVID-19
COVID-19 Vaccines May Give Protection for Years: Studies
CDC Offers Details on SARS-CoV-2 Vaccine Breakthrough Infections
COVID-19 Symptom Exacerbation Leading Cause of Reencounters
Pfizer, AstraZeneca COVID-19 Vaccines Effective Against Indian Variant: Study
Risk for Post-COVID-19 Clinical Sequelae Examined in Adults
Less Than 1 Percent of COVID-19 Patients Experience Recurrence
mRNA Vaccines Effective for Preventing Symptomatic COVID-19
Ohio Lottery Will Award $1 Million to Five Vaccinated Residents
After Setbacks, Sanofi/GSK COVID-19 Vaccine Performs Well in Early Trial
Risk for Severe Effects Low After SARS-CoV-2 Without Hospitalization
WHO Increases Warning About Indian COVID-19 Variant
NYC, NJ, and Connecticut to Ease COVID-19 Capacity Restrictions
U.K. to Ease Lockdown Measures by June 21
U.S. Will Help India in Fight Against COVID-19: Biden
Risk for Subsequent SARS-CoV-2 Infection Lower With Seropositivity
Third Booster COVID-19 Vaccine Shot Available by Fall: Moderna
B.1.1.7 SARS-CoV-2 Variant More Transmissible but Not Linked to More Severe...
Chinese COVID-19 Vaccines Not Very Effective: Official
Blood Type Not Associated With COVID-19 Outcomes
CDC: Risk for Catching Coronavirus From Surfaces Is Low
COVID-19 Cases Climb in the Midwest as British Variant Takes Hold...
‘Double Mutant’ Coronavirus Variant Detected in US for First Time
Faster-Spreading COVID-19 Variant Expanding in United States
​Biden, Top Health Officials Warn of Risk for Another COVID-19 Surge
WHO: Coronavirus Likely Transmitted From Bats to Humans Through Another Mammal
China Briefs Foreign Diplomats on COVID-19 Origins Research
SARS-CoV-2 Viral-Specific Antibody Response Profiles Vary With Age
Seroprevalence of Anti-SARS-CoV-2 Antibodies Reported for Wuhan
New Symptoms Common Four Months After COVID-19
Protection Against Repeat SARS-CoV-2 Infection About 80 Percent
COVID-19 Antibodies Found in One in Five U.S. Blood Donations
CDC Classifies Two Coronavirus Strains as ‘Variants of Concern’
Mortality Increased in Association With SARS-CoV-2 U.K. Variant
Immune Response Strong After One Dose in COVID-19-Seropositive Vaccinees
Two Cases of SARS-CoV-2 Variant P.1 Identified in Minnesota
Preliminary Data in Israel Show COVID-19 Vaccines Effectively Prevent Severe Disease
New Coronavirus Variant Sweeping Through New York City
New Coronavirus Variant Surging in California
SARS-CoV-2, COVID-19 Rates Decreased After One Vaccine Dose
Novel SARS-CoV-2 Variant From California Spreading Widely
Shortage Forces Temporary Closure of Five LA COVID-19 Vaccination Sites
State Mask Mandates Tied to Drop in COVID-19 Hospitalization Growth Rate
Most Americans Unhappy With U.S. Vaccine Rollout: Poll
Unlikely That Coronavirus Leaked From Chinese Lab: WHO Expert
South Africa Considering J&J Vaccine as Next Step
COVID-19 Vaccine Scammers Proliferating on the ‘Dark Web’
South Africa Delays AstraZeneca Vaccine Rollout
United States Sees Continued Drop in New COVID-19 Cases
High Efficacy Reported for Sputnik V COVID-19 Vaccine
Companies Developing Vaccines Against New Coronavirus Variants
First Federal COVID-19 Vaccination Sites to Open in California
Biden Administration to Start Shipping COVID-19 Vaccines Directly to U.S. Pharmacies
WHO Team Probing COVID-19 Origins Visits Wuhan Research Center
Mutation That Helps Coronavirus Evade Vaccines Showing Up in British Variant
>60 Percent Receiving COVID-19 Vaccine in U.S. Are Non-Hispanic Whites
Moderna Wants to Increase Number of Doses in COVID-19 Vaccine Vials
WHO Team Probing COVID-19 Origins Visits Wuhan Food Markets
CDC Makes Masks Mandatory on Planes and Public Transportation
New COVID-19 Variants May Weaken Efficacy of Vaccines
EU Regulator Approves Oxford-AstraZeneca COVID-19 Vaccine
Nearly Half of U.S. Adults Want the COVID-19 Vaccine as Soon...
Retired Doctors, Nurses Will Be Approved to Give COVID-19 Vaccine, White...
Large Number of SARS-CoV-2-Infected Are Asymptomatic
Brazilian Coronavirus Variant Found in Minnesota
U.S. to Get Fewer Vials of Pfizer COVID-19 Vaccine
Moderna COVID-19 Vaccine Effective Against British, South African Variants
Adults Delaying Even Emergency Care During COVID-19
New York City May Run Out of COVID-19 Vaccines
Expert Panel Criticizes WHO, China for Pandemic Response
Previous COVID-19 Infection May Confer Immunity for at Least Five Months
1
2
Page 1 of 2